Epstein–Barr virus (EBV) is associated with a still growing spectrum of clinical disorders,
ranging from acute and chronic inflammatory diseases to lymphoid and epithelial …

The Epstein–Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) is a key effector of
EBV-mediated B cell transformation. LMP1 displays potent oncogenic properties in rodent …

Abstract The Epstein-Barr virus latent membrane protein (LMP) 1 is a versatile protein that
has profound effects on target cells through its effect on constitutive cellular proteins, eg …

The EBV latent membrane protein 1 (LMP1) is an integral membrane protein that acts like a
constitutively activated receptor. LMP1 interacts with members of the tumor necrosis factor …

Epstein–Barr virus (EBV) is a herpes virus that is associated with several human cancers.
Infection of B cells by EBV leads to their induction and maintenance of proliferation and …

Nasopharyngeal carcinoma (NPC) is an uncommon cancer, which has a distinctive ethnic
and geographic distribution. Etiology of NPC is considered to be related with a complex …

EBV infection causes mononucleosis and is associated with specific subsets of B cell
lymphomas. Immunosuppressed patients such as organ transplant recipients are particularly …

CD40 is an important regulator of diverse aspects of the immune response including the T-
cell-dependent humoral immune response, the development of antigen-presenting cells …

The oncogene latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) without a
ligand drives proliferation of EBV-infected B cells. Its levels vary in cells of clonal populations …

Epstein–Barr virus encodes integral membrane proteins LMP1 and LMP2A in transformed
lymphoblastoid cell lines. We now find that LMP1 associates with the cell cytoskeleton …